AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,910,067 | -39.8% | 11,114,431 | +4.6% | 0.01% | -40.0% |
| Q2 2023 | $117,807,558 | -29.2% | 10,622,864 | -2.0% | 0.01% | +25.0% |
| Q1 2023 | $166,365,040 | +52.2% | 10,838,114 | +120.0% | 0.01% | -27.3% |
| Q4 2022 | $109,294,139 | +92.7% | 4,925,378 | +41.8% | 0.01% | +83.3% |
| Q3 2022 | $56,703,000 | +2.4% | 3,472,319 | -8.8% | 0.01% | 0.0% |
| Q2 2022 | $55,347,000 | -21.4% | 3,809,123 | -0.0% | 0.01% | 0.0% |
| Q1 2022 | $70,387,000 | -21.6% | 3,810,915 | +0.9% | 0.01% | -14.3% |
| Q4 2021 | $89,768,000 | -4.9% | 3,776,524 | -1.5% | 0.01% | 0.0% |
| Q3 2021 | $94,423,000 | +12.6% | 3,833,667 | +12.9% | 0.01% | 0.0% |
| Q2 2021 | $83,874,000 | +12.0% | 3,394,315 | -1.1% | 0.01% | +16.7% |
| Q1 2021 | $74,887,000 | -14.3% | 3,433,588 | +0.3% | 0.01% | -25.0% |
| Q4 2020 | $87,383,000 | +2.8% | 3,424,135 | +13.4% | 0.01% | -11.1% |
| Q3 2020 | $84,980,000 | +6.2% | 3,018,831 | +6.6% | 0.01% | 0.0% |
| Q2 2020 | $80,056,000 | – | 2,832,852 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |